• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Clinical Correlates and Prognostic Value of B-Type Natriuretic Peptide in Left Ventricular Assist Device Recipients With Cardiogenic Shock: Insights from INTERMACS.B型利钠肽在心源性休克左心室辅助装置受者中的临床关联及预后价值：来自INTERMACS的见解
Am J Cardiol. 2023 Oct 15;205:451-453. doi: 10.1016/j.amjcard.2023.07.177. Epub 2023 Sep 4.
2
Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.在各种病因所致难治性心源性休克中使用连续流体外心室辅助装置进行桥接决策治疗。
Circ Heart Fail. 2014 Sep;7(5):799-806. doi: 10.1161/CIRCHEARTFAILURE.113.000271. Epub 2014 Jul 15.
3
Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.在使用左右腋动脉入路的INTERMACS II级心源性休克患者中使用Impella 5.0支持
Artif Organs. 2015 Aug;39(8):660-3. doi: 10.1111/aor.12529. Epub 2015 Jul 6.
4
Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.体外连续流心室辅助装置（BR16010）作为严重心力衰竭或难治性心源性休克桥接决策治疗的安全性和有效性评估：单臂非随机、非对照、研究者发起的临床试验研究方案。
Cardiovasc Drugs Ther. 2018 Aug;32(4):373-379. doi: 10.1007/s10557-018-6796-8.
5
Bridge to durable left ventricular assist device for refractory cardiogenic shock.桥接至耐用型左心室辅助装置治疗难治性心原性休克。
J Thorac Cardiovasc Surg. 2017 Apr;153(4):752-762.e5. doi: 10.1016/j.jtcvs.2016.10.085. Epub 2016 Nov 16.
6
Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome.在植入左心室辅助装置之前进行体外生命支持可改善患者的INTERMACS水平和预后。
PLoS One. 2017 Mar 30;12(3):e0174262. doi: 10.1371/journal.pone.0174262. eCollection 2017.
7
Clinical experience with temporary right ventricular mechanical circulatory support.临时右心室机械循环支持的临床经验。
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1885-1891. doi: 10.1016/j.jtcvs.2018.04.094. Epub 2018 May 1.
8
Treatment of cardiogenic shock with left ventricular assist device combined with cardiac resynchronization therapy: a case report.左心室辅助装置联合心脏再同步治疗用于心源性休克的治疗：一例病例报告
J Cardiothorac Surg. 2010 Jul 2;5:54. doi: 10.1186/1749-8090-5-54.
9
Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function.左心室辅助装置植入术治疗严重心力衰竭患者早期死亡的预测因素：INTERMACS 分级和肾功能的意义。
Circ J. 2012;76(7):1631-8. doi: 10.1253/circj.cj-11-1452. Epub 2012 Apr 7.
10
Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.用于治疗心源性休克患者的经皮左心室辅助装置
Curr Opin Crit Care. 2007 Oct;13(5):521-7. doi: 10.1097/MCC.0b013e3282efd5bc.

引用本文的文献

1
Differences in natriuretic peptide response in self-identified white and black individuals: a physiological clinical trial.自我认定的白人和黑人个体中利钠肽反应的差异：一项生理学临床试验。
Nat Commun. 2025 Feb 13;16(1):1621. doi: 10.1038/s41467-024-55648-2.
2
Current and novel biomarkers in cardiogenic shock.心源性休克中的当前及新型生物标志物
Eur J Heart Fail. 2025 Jan 17. doi: 10.1002/ejhf.3531.
3
Cardiogenic Shock: Focus on Non-Cardiac Biomarkers.心原性休克：关注非心脏生物标志物。
Curr Heart Fail Rep. 2024 Dec;21(6):604-614. doi: 10.1007/s11897-024-00676-8. Epub 2024 Jul 30.

本文引用的文献

1
Sex-Associated Differences in the Clinical Outcomes of Left Ventricular Assist Device Recipients: Insights From Interagency Registry for Mechanically Assisted Circulatory Support.性别对左心室辅助装置接受者临床结局的影响：来自机械循环辅助支持机构注册研究的结果。
Circ Heart Fail. 2023 Jun;16(6):e010189. doi: 10.1161/CIRCHEARTFAILURE.122.010189. Epub 2023 May 26.
2
Mechanical Circulatory Support Devices Among Patients With Familial Dilated Cardiomyopathy: Insights From the INTERMACS.家族性扩张型心肌病患者的机械循环支持装置：来自INTERMACS的见解
Circulation. 2022 Nov 8;146(19):1486-1488. doi: 10.1161/CIRCULATIONAHA.122.061143. Epub 2022 Nov 7.
3
Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar.左心室辅助装置治疗的趋势和结果：美国心脏病学会焦点研讨会。
J Am Coll Cardiol. 2022 Mar 22;79(11):1092-1107. doi: 10.1016/j.jacc.2022.01.017.
4
Natriuretic Peptide Deficiency in Obese Individuals: Mechanistic Insights From Healthy Organ Donor Cohort.肥胖个体中的利钠肽缺乏：来自健康器官捐献者队列的机制性见解
J Am Coll Cardiol. 2021 Jun 22;77(24):3138-3140. doi: 10.1016/j.jacc.2021.04.055.
5
Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals.利钠肽和血压的生物节律在瘦素和肥胖个体中的变化。
J Am Coll Cardiol. 2021 May 11;77(18):2291-2303. doi: 10.1016/j.jacc.2021.03.291.
6
Obesity and Serial NT-proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE-IT Trial.肥胖与射血分数降低的心力衰竭有指导的医学治疗中连续 NT-proBNP 水平：来自 GUIDE-IT 试验的见解。
J Am Heart Assoc. 2021 Apr 6;10(7):e018689. doi: 10.1161/JAHA.120.018689. Epub 2021 Mar 23.
7
Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial.心力衰竭管理中 NT-proBNP 水平的种族差异：来自 GUIDE-IT 试验的见解。
Circulation. 2020 Sep 8;142(10):1018-1020. doi: 10.1161/CIRCULATIONAHA.120.046374.
8
Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.基于种族的人口统计学、人体测量学和 N-末端 pro B 型利钠肽的临床相关性。
Int J Cardiol. 2019 Jul 1;286:145-151. doi: 10.1016/j.ijcard.2019.02.034. Epub 2019 Feb 21.
9
Established and Emerging Roles of Biomarkers in Heart Failure.生物标志物在心衰中的既定和新兴作用。
Circ Res. 2018 Aug 17;123(5):614-629. doi: 10.1161/CIRCRESAHA.118.312706.
10
Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies.预测心室辅助装置植入后右心衰竭：观察性研究的系统评价和荟萃分析。
Eur J Heart Fail. 2017 Jul;19(7):926-946. doi: 10.1002/ejhf.733. Epub 2017 Mar 31.

Clinical Correlates and Prognostic Value of B-Type Natriuretic Peptide in Left Ventricular Assist Device Recipients With Cardiogenic Shock: Insights from INTERMACS.

作者信息

Shetty Naman S, Patel Nirav, Parcha Vibhu, Vekariya Nehal, Xie Rongbing, Arora Garima, Arora Pankaj

机构信息

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.

Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

出版信息

Am J Cardiol. 2023 Oct 15;205:451-453. doi: 10.1016/j.amjcard.2023.07.177. Epub 2023 Sep 4.

DOI:10.1016/j.amjcard.2023.07.177
PMID:37666017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10529339/
Abstract
摘要